Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?

被引:0
|
作者
Qiang Zhou [1 ]
Hao Cai [1 ]
Ming-Hao Xu [1 ]
Yao Ye [2 ]
Xiao-Long Li [1 ]
Guo-Ming Shi [1 ]
Cheng Huang [1 ]
Xiao-Dong Zhu [1 ]
Jia-Bin Cai [1 ]
Jian Zhou [1 ]
Jia Fan [1 ]
Yuan Ji [2 ]
Hui-Chuan Sun [1 ]
Ying-Hao Shen [1 ]
机构
[1] Department of Liver Surgery,Liver Cancer Institute,Zhongshan Hospital,and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education),Fudan University
[2] Department of Pathology,Zhongshan Hospital,Fudan University
基金
上海市自然科学基金;
关键词
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
Background:The incidence of combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma(c HCC-ICC) is relatively low,and the knowledge about the prognosis of c HCC-ICC remains obscure.In the study,we aimed to screen existing primary liver cancer staging systems and shed light on the prognosis and risk factors for c HCC-ICC.Methods:We retrospectively reviewed 206 c HCC-ICC patients who received curative surgical resection from April 1999 to March 2017.The correlation of survival measures with the histological types or with tumor staging systems was determined and predictive values of tumor staging systems with c HCC-ICC prognosis were compared.Results:The histological type was not associated with overall survival(OS)(P = 0.338) or disease-free survival(DFS)(P = 0.843) of patients after curative surgical resection.BCLC,TNM for HCC,and TNM for ICC stages correlated with both OS and DFS in c HCC-ICC(all P < 0.05).The predictive values of TNM for HCC and TNM for ICC stages were similar in terms of predicting postoperative OS(P = 0.798) and DFS(P = 0.191) in c HCC-ICC.TNM for HCC was superior to BCLC for predicting postoperative OS(P = 0.022) in c HCC-ICC.Conclusion:The TNM for HCC staging system should be prioritized for clinical applications in predicting c HCC-ICC prognosis.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [21] Intrahepatic cholangiocarcinoma: how do hepatectomy outcomes compare to liver metastases and hepatocellular carcinoma?
    Diggs, Laurence P.
    Fagenson, Alexander M.
    Putatunda, Vijay
    Lau, Kwan Nang
    Grandhi, Miral S.
    Pitt, Henry A.
    HPB, 2023, 25 (11) : 1420 - 1428
  • [22] A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
    Ru-Chen Xu
    Fu Wang
    Jia-Lei Sun
    Weinire Abuduwaili
    Guang-Cong Zhang
    Zhi-Yong Liu
    Tao-Tao Liu
    Ling Dong
    Xi-Zhong Shen
    Ji-Min Zhu
    Journal of Translational Medicine, 20
  • [23] Primary Combined Hepatocellular-Cholangiocarcinoma: A Case of Underdiagnosed Primary Liver Cancer
    Ayas, Mohamad F.
    Affas, Saif
    Ayas, Zayd
    Chand, Momal
    Hadid, Tarik
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [24] A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma
    Xu, Ru-Chen
    Wang, Fu
    Sun, Jia-Lei
    Abuduwaili, Weinire
    Zhang, Guang-Cong
    Liu, Zhi-Yong
    Liu, Tao-Tao
    Dong, Ling
    Shen, Xi-Zhong
    Zhu, Ji-Min
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [25] Primary Combined Hepatocellular Carcinoma-cholangiocarcinoma: A Case Report for Under-Diagnosed Primary Liver Cancer
    Affas, Saif
    Malapati, Sindhu
    Chand, Momal
    Hadid, Tarik
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1244 - S1245
  • [26] Intrahepatic cholangiocarcinoma in patients undergoing liver transplantation for hepatocellular carcinoma
    Dayangac, M.
    Bozkurt, B.
    Gurcan, Inan N.
    Dogusoy, Bulbul G.
    Tokat, Y.
    TRANSPLANTATION, 2018, 102 : 275 - 276
  • [27] Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
    Kis, Bela
    El-Haddad, Ghassan
    Sheth, Rahul A.
    Parikh, Nainesh S.
    Ganguli, Suvranu
    Shyn, Paul B.
    Choi, Junsung
    Brown, Karen T.
    CANCER CONTROL, 2017, 24 (03)
  • [28] NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project
    Petrick, Jessica L.
    Sahasrabuddhe, Vikrant V.
    Chan, Andrew T.
    Alavanja, Michael C.
    Beane-Freeman, Laura E.
    Buring, Julie E.
    Chen, Jie
    Chong, Dawn Q.
    Freedman, Neal D.
    Fuchs, Charles S.
    Michael Gaziano, John
    Giovannucci, Edward
    Graubard, Barry I.
    Hollenbeck, Albert R.
    Hou, Lifang
    Jacobs, Eric J.
    King, Lindsay Y.
    Koshiol, Jill
    Lee, I-Min
    Linet, Martha S.
    Palmer, Julie R.
    Purdue, Mark P.
    Rosenberg, Lynn
    Schairer, Catherine
    Sesso, Howard D.
    Sigurdson, Alice J.
    Wactawski-Wende, Jean
    Zeleniuch-Jacquotte, Anne
    Campbell, Peter T.
    McGlynn, Katherine A.
    CANCER PREVENTION RESEARCH, 2015, 8 (12) : 1156 - 1162
  • [29] Primary Liver Cancers - Hepatocellular Carcinoma and Cholangiocarcinoma
    Soysal, Savas Deniz
    Kollmar, Otto
    THERAPEUTISCHE UMSCHAU, 2021, 78 (10) : 585 - 588
  • [30] Double primary liver cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma) in a patient with hepatitis C virus-related cirrhosis
    Inaba, Keisuke
    Suzuki, Shohachi
    Sakaguchi, Takanori
    Kobayasi, Yoshimasa
    Takehara, Yasuo
    Miura, Katsutoshi
    Baba, Satoshi
    Nakamura, Satoshi
    Konno, Hiroyuki
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2007, 14 (02): : 204 - 209